MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05161naaaa2201201uu 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
https://directory.doabooks.org/handle/20.500.12854/68985 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220714191636.0 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
books978-3-03936-949-2 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039369485 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039369492 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.3390/books978-3-03936-949-2 |
| Terms of availability |
doi |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
dc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
M |
| Source |
bicssc |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Daniels, Rolf |
| Relator code |
edt |
| 9 (RLIN) |
1614920 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Semisolid Dosage |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Basel, Switzerland |
| Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
| Date of publication, distribution, etc |
2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 electronic resource (182 p.) |
| 506 0# - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Open Access |
| Source of term |
star |
| Standardized terminology for access restriction |
Unrestricted online access |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of "ointments" as dosage forms was initiated in the 1950s. It was only from then on that the intensive physico-chemical characterization of ointments as well as the inclusion of dermatological aspects led to a comprehensive understanding of the various interactions between the vehicle, the active ingredient and the skin. From then on, many researchers were involved in optimizing semi-solid formulations with respect to continuously changing therapeutic and patient needs. Aspects that have been dealt with were the optimization of dermato-biopharmaceutical properties and many different issues related to patient compliance, such as skin tolerance, applicability, and cosmetic appeal. Moreover, processing technology has been improved and analytical techniques were developed and refined in order to enable the improved characterization of the formulation itself as well as its interaction with the skin. This Special Issue serves to highlight and capture the contemporary progress and current research on semi-solid formulations as dermal drug delivery systems. We invite articles on all aspects of semi-solid formulations, highlighting the research currently undertaken to improve and better understand these complex drug delivery systems with respect to their formulation, processing and characterization issues. |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
|---|
| Terms governing use and reproduction |
Creative Commons |
| -- |
https://creativecommons.org/licenses/by/4.0/ |
| -- |
cc |
| -- |
https://creativecommons.org/licenses/by/4.0/ |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine |
| Source of heading or term |
bicssc |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
dermal drug delivery |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
diffusion cell |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Franz diffusion |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Skin-PAMPA |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Strat-M® membrane |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
nanocarrier |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
nonivamide |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
methyl cellulose |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
skin penetration |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
substantivity |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
thermogel |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
tacrolimus formulation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
nanogels |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
drug delivery |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
human excised skin |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Jurkat cells |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
in situ hydrogel-forming powder |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
nitric oxide-releasing formulation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
S-nitrosoglutathione (GSNO) |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
antibacterial |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
wound dressing |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
wound healing |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
dermal delivery |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
porcine skin |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
in vitro permeation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
methadone |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
pain |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
in vitro |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
permeation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
niacinamide |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
solvent |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
PAMPA |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
skin |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
curcumin |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
deformable liposomes |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
liposome surface charge |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
hydrogel |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
chitosan |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
wound therapy |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
IVRT |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
metronidazole |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
topical cream |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
semisolid dosage forms |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
sameness |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
FDA's SUPAC-SS guidance |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
acceptance criteria |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
positive and negative controls |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
discriminatory ability |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Amphotericin B |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Sepigel 305® |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Leishmania infantum |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cutaneous leishmaniasis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
topical treatment |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
birch bark extract |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
oleogels |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
hydrogen bonding |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
triterpene |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
rheology |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
gel strength |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
eosinophilic esophagitis |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
budesonide |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
xanthan gum |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
guar gum |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
mucoadhesion |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
esophagus permeability |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
rheological characterization |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
pediatric medicine |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
compounded preparation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
non-ionic emulsifiers |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
intercellular lipids |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
confocal Raman spectroscopy (CRS) |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
polyethylene glycol alkyl ethers |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
polyethylene glycol sorbitan fatty acid esters |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
n/a |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lunter, Dominique |
| Relator code |
edt |
| 9 (RLIN) |
1614921 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Daniels, Rolf |
| Relator code |
oth |
| 9 (RLIN) |
1614920 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lunter, Dominique |
| Relator code |
oth |
| 9 (RLIN) |
1614921 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/2753">https://mdpi.com/books/pdfview/book/2753</a> |
| -- |
0 |
| Public note |
DOAB: download the publication |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/68985">https://directory.doabooks.org/handle/20.500.12854/68985</a> |
| -- |
0 |
| Public note |
DOAB: description of the publication |
